Unternehmen G9pharma co., LTD
Aktien
A078650
KR7078650009
A078650
Medizinische Versorgung
Kurzporträt
Mitarbeiterzahl: 7
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Taek-Hwe Jang
CEO | Chief Executive Officer | 43 | - |
Jae-Gyu Park
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Dong-Gwon Kim
AUD | Comptroller/Controller/Auditor | 71 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Jae-Eon Jung
BRD | Director/Board Member | 65 | - |
Seok-Hwan Choi
BRD | Director/Board Member | 53 | - |
Taek-Hwe Jang
CEO | Chief Executive Officer | 43 | - |
Sung-Kyu Kim
BRD | Director/Board Member | 69 | - |
Su-Dong Kim
BRD | Director/Board Member | 58 | - |
Ju-Hee Kim
BRD | Director/Board Member | 53 | - |
Dae-Hee Shin
BRD | Director/Board Member | 66 | - |
Na Lee
BRD | Director/Board Member | 43 | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 4 078 777 | 3 614 663 ( 88,62 %) | 0 | 88,62 % |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+10.91% | 39.96 Mrd. | |
-4.66% | 18.22 Mrd. | |
-23.47% | 2.15 Mrd. | |
-7.23% | 1.58 Mrd. | |
+22.95% | 1.16 Mrd. | |
-35.53% | 733 Mio. | |
-37.31% | 716 Mio. | |
-11.55% | 633 Mio. | |
+20.00% | 477 Mio. |